[Management of milder forms of hypertension using new beta-receptor blockaders].
D000284:Administration, Oral; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D055598:Chemical Phenomena; D002621:Chemistry; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D011412:Propanolamines / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines
Zur Behandlung milder Hypertonieformen mit neuen Betarezeptoren-Blockern.